ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

AGE AgeX Therapeutics Inc

11,10
0,00 (0,00%)
26 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
AgeX Therapeutics Inc AGE AMEX Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 11,10 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
11,10 11,10
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
22.3.202422:27GLOBEAgeX Therapeutics Reports Fourth Quarter and Annual 2023..
07.3.202422:49EDGAR2Form 425 - Prospectuses and communications, business..
07.3.202422:47EDGAR2Form 8-K - Current report
07.3.202413:47EDGAR2Form SC 13D/A - General statement of acquisition of..
14.2.202422:01EDGAR2Form SC 13D/A - General statement of acquisition of..
14.2.202406:15EDGAR2Form EFFECT - Notice of Effectiveness
06.2.202422:05EDGAR2Form 8-K - Current report
05.2.202413:19EDGAR2Form SC 13D/A - General statement of acquisition of..
19.1.202422:05EDGAR2Form 8-K - Current report
17.1.202422:19EDGAR2Form SC 13D/A - General statement of acquisition of..
16.1.202415:11EDGAR2Form S-4/A - Registration of securities, business..
11.1.202422:05EDGAR2Form 8-K - Current report
09.1.202422:16EDGAR2Form SC 13D/A - General statement of acquisition of..
05.1.202422:05EDGAR2Form 8-K - Current report
28.12.202322:02EDGAR2Form 8-K - Current report
18.12.202322:25EDGAR2Form 8-K - Current report
13.12.202323:11EDGAR2Form SC 13D/A - General statement of acquisition of..
08.12.202322:05EDGAR2Form 8-K - Current report
01.12.202322:05EDGAR2Form 8-K - Current report
17.11.202322:05EDGAR2Form 8-K - Current report
16.11.202322:01EDGAR2Form SC 13D/A - General statement of acquisition of..
15.11.202315:38EDGAR2Form DEF 14A - Other definitive proxy statements
14.11.202322:25EDGAR2Form 8-K - Current report
14.11.202322:05BWAgeX Therapeutics Reports Third Quarter 2023 Financial..
07.11.202322:06EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07.11.202322:05EDGAR2Form DEF 14A - Other definitive proxy statements
06.11.202322:05EDGAR2Form 8-K - Current report
01.11.202321:28EDGAR2Form SC 13D/A - General statement of acquisition of..
06.10.202322:05EDGAR2Form 8-K - Current report
22.9.202322:05EDGAR2Form PRE 14A - Other preliminary proxy statements
15.9.202322:05EDGAR2Form 8-K - Current report
08.9.202322:05EDGAR2Form 8-K - Current report
30.8.202322:05EDGAR2Form 425 - Prospectuses and communications, business..
30.8.202313:20EDGAR2Form 8-K - Current report
30.8.202313:00BWSerina Therapeutics and AgeX Therapeutics Enter into Merger..
25.8.202322:05EDGAR2Form 8-K - Current report
24.8.202322:48EDGAR2Form SC 13D/A - General statement of acquisition of..
14.8.202322:25EDGAR2Form 8-K - Current report
14.8.202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:05BWAgeX Therapeutics Reports Second Quarter 2023 Financial..
04.8.202322:05EDGAR2Form 8-K - Current report
25.7.202300:28BWAgeX Therapeutics Closes $36,000,000 Debt Exchange for..
21.7.202323:32BWAgeX Therapeutics Announces $36,000,000 Debt Exchange for..
21.7.202323:29EDGAR2Form 8-K - Current report
07.7.202322:05EDGAR2Form 8-K - Current report
23.5.202322:05BWAgeX Therapeutics Announces Appeal of NYSE American..
12.5.202322:05BWAgeX Therapeutics Reports First Quarter 2023 Financial..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock